[go: up one dir, main page]

WO2005091804A3 - Inhibiteurs de la famille des paramyxovirus et leurs methodes d'utilisation - Google Patents

Inhibiteurs de la famille des paramyxovirus et leurs methodes d'utilisation Download PDF

Info

Publication number
WO2005091804A3
WO2005091804A3 PCT/US2005/004565 US2005004565W WO2005091804A3 WO 2005091804 A3 WO2005091804 A3 WO 2005091804A3 US 2005004565 W US2005004565 W US 2005004565W WO 2005091804 A3 WO2005091804 A3 WO 2005091804A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
paramyxovirus
family inhibitors
paramyxovirus family
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/004565
Other languages
English (en)
Other versions
WO2005091804A2 (fr
Inventor
Richard K Plemper
Richard W Compans
James P Snyder
Aiming Sun
Dennis C Liotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of WO2005091804A2 publication Critical patent/WO2005091804A2/fr
Publication of WO2005091804A3 publication Critical patent/WO2005091804A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des méthodes pour traiter des paramyxovirus, des vaccins pour une protection contre les paramyxovirus, et une composition pharmaceutique comprenant un composé inhibiteur ou une composition inhibitrice de paramyxovirus.
PCT/US2005/004565 2004-02-11 2005-02-11 Inhibiteurs de la famille des paramyxovirus et leurs methodes d'utilisation Ceased WO2005091804A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54352104P 2004-02-11 2004-02-11
US60/543,521 2004-02-11

Publications (2)

Publication Number Publication Date
WO2005091804A2 WO2005091804A2 (fr) 2005-10-06
WO2005091804A3 true WO2005091804A3 (fr) 2006-04-20

Family

ID=35056640

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/004565 Ceased WO2005091804A2 (fr) 2004-02-11 2005-02-11 Inhibiteurs de la famille des paramyxovirus et leurs methodes d'utilisation

Country Status (1)

Country Link
WO (1) WO2005091804A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729059B2 (en) * 2007-02-09 2014-05-20 Emory University Paramyxovirus family inhibitors and methods of use thereof
WO2020099383A1 (fr) 2018-11-13 2020-05-22 Janssen Vaccines & Prevention B.V. Protéines f du vrs sous forme pré-fusion stabilisées
CN115461076A (zh) * 2020-04-02 2022-12-09 扬森疫苗与预防公司 稳定化的疫苗组合物
EP4603477A1 (fr) * 2024-02-16 2025-08-20 Consejo Superior De Investigaciones Científicas Inhibiteurs de la protéine accessoire orf9b du coronavirus

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835168A (en) * 1985-12-16 1989-05-30 Eli Lilly And Company Thiadiazole antiviral agents
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
US20030187063A1 (en) * 2001-03-08 2003-10-02 Pooran Chand Compounds useful for inhibiting paramyxovirus neuraminidase

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835168A (en) * 1985-12-16 1989-05-30 Eli Lilly And Company Thiadiazole antiviral agents
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
US20030187063A1 (en) * 2001-03-08 2003-10-02 Pooran Chand Compounds useful for inhibiting paramyxovirus neuraminidase

Also Published As

Publication number Publication date
WO2005091804A2 (fr) 2005-10-06

Similar Documents

Publication Publication Date Title
WO2008127275A3 (fr) Composés pyrrolidone en tant qu&#39;inhibiteurs d&#39;hydrolase d&#39;arnt peptidyle bactérienne et utilisations de ceux-ci
WO2006066133A3 (fr) Inhibiteurs d&#39;histone desacetylase
WO2007125310A3 (fr) Combinaisons pharmaceutiques
WO2009099596A3 (fr) Inhibiteurs de sérine protéase macrocycliques
WO2008073452A8 (fr) Compositions, synthèse et procédés d&#39;utilisation d&#39;inhibiteurs de cholinestérase à base d&#39;indanone
WO2006071762A3 (fr) Inhibiteurs de dipeptidyl-peptidase iv a base de pyrimidine et methodes associees
WO2007139860A3 (fr) Inhibiteurs hétérobicycliques des métalloprotéases
WO2009082701A8 (fr) Inhibiteurs de hcv protéase et leurs utilisations
WO2007084390A3 (fr) Inhibiteurs des histone desacetylases
WO2008063671A3 (fr) Inhibiteurs de métalloprotéase hétérobicycliques
WO2008016883A3 (fr) Inhibiteurs de kallicréine plasmatique
WO2008055068A3 (fr) Inhibiteurs de l&#39;histone désacétylase
WO2006078752A3 (fr) Inhibiteurs d&#39;adn-methyltransferase
WO2007059230A3 (fr) 1h-benzimidazole-4-carboxamides substitues efficaces en tant qu’inhibiteurs de parp
CL2007000918A1 (es) Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica.
WO2008042480A3 (fr) Inhibiteurs époxyde de cystéine protéases
WO2007109105A3 (fr) Inhibition des flavivirus par des sultames et composes apparentes
WO2005084654A3 (fr) Procedes et compositions pour le traitement ou la prevention de troubles psychiatriques avec des inhibiteurs de cox-2 seuls et en combinaison avec des antidepresseurs
WO2008048121A3 (fr) Composés et compositions
WO2007099171A3 (fr) Bicyclopyrazoles actifs comme inhibiteurs de la kinase
WO2008098239A3 (fr) Inhibiteurs de la famille des paramyxovirus et procédés d&#39;utilisation de ceux-ci
WO2006124684A3 (fr) Polytherapie
NO20076566L (no) Ny fremgangsmate for behandling av hyperlipidemi
WO2005041904A3 (fr) Inhibiteurs de la protease de coronavirus et procedes de leur utilisation
WO2005091804A3 (fr) Inhibiteurs de la famille des paramyxovirus et leurs methodes d&#39;utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase